| Section 86-1.42 - Potentially preventable negative outcomes |
|
| Section 86-1.46 - Empire Clinical Research Investigator Program (ECRIP) |
|
| Section 86-2.39 - Closures, mergers, acquisitions, consolidations and restructurings |
|
| SubPart 86-8 - Outpatient Services: Ambulatory Patient Group |
|
| Section 86-8.2 - Definitions |
|
| Section 86-8.4 - Capital reimbursement and rate add-ons |
|
| Section 86-8.7 - APGs and relative weights |
|
| Section 86-8.9 - Diagnostic coding and rate computation |
|
| Section 86-8.10 - Exclusions from payment |
|
| Section 86-8.15 - Closures, mergers, acquisitions, consolidations, restructurings and inpatient bed de-certifications |
|
| Subpart 98-4 - Mental Health and Substance Use Disorder Treatment Parity Compliance Program |
|
| Section 98-4.1 - Purpose |
|
| Section 98-4.2 - Applicability |
|
| Section 98-4.3 - Definitions |
|
| Section 98-4.4 - Mental health and substance use disorder parity compliance program |
|